— Know what they know.
Not Investment Advice
Also trades as: SBS.DE (XETRA) · $vol 0M · 0RAR.L (LSE) · $vol 0M

STSEY OTC

Stratec SE
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +8.0% 1Y: -17.8% 3Y: -78.5% 5Y: -78.1%
$5.51
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 47 · $1.7B mcap · 33M float · 0.0003% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
$49M +150.8% ▲
5Y CAGR: +18.0%
Capital Expenditures
$18M -4.4% ▼
5Y CAGR: -7.5%
Free Cash Flow
$31M +1425.4% ▲
Dividends Paid
$7M +43.3% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$14M +25.5% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$25M$40M$29M$13M$16M
Depreciation & Amort.$23M$18M$17M$18M$19M
Stock-Based Comp.$6M$2M$3M$967K$0
Change in Working Capital-$18M$88K-$49M-$7M$10M
Other Non-Cash Items-$4M$2M$12M-$6M$4M
Operating Cash Flow$32M$63M$10M$19M$49M
— Investing Activities —
Capital Expenditures-$26M-$20M-$19M-$8M-$10M
Acquisitions (Net)$3M$81K$17K-$27M$0
Investment Purchases-$5K-$81K-$17K$0$0
Investment Sales$837K$24K$5K$5K$0
Other Investing$49K$81K$17K-$9M-$6M
Investing Cash Flow-$22M-$20M-$19M-$44M-$16M
— Financing Activities —
Net Debt Issuance$13M-$25M-$4M$47M-$14M
Stock Repurchased$0$0$0$0$0
Dividends Paid-$10M-$11M-$12M-$12M-$7M
Other Financing$0$0$0$0$0
Financing Cash Flow$5M-$34M-$14M$35M-$20M
Net Change in Cash$15M$10M-$25M$11M$14M
Cash End of Period$38M$47M$23M$34M$47M
Free Cash Flow$6M$43M-$9M$2M$31M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms